Effectiveness of Paricalcitol in Reducing Parathyroid Hormone Levels in X-linked Hypophosphatemic Rickets
Conditions
Hyperparathyroidism | Hypophosphatemia, Familial
What is the purpose of this trial?
The purpose of this study is to determine the effectiveness of paricalcitol, a form of synthetic vitamin D, in lowering parathyroid hormone (PTH) levels and reducing disease symptoms in children and adults with X-linked hypophosphatemic (XLH) rickets.
Participation Guidelines
- Age:
- 9 Years and older
- Gender:
- Both
Click here for detailed information about who can participate in this trial.
- Sponsor:
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Yale University - Dates:
- January 2007
- Last Updated:
- October 18, 2012
- Study HIC#:
- 0607001636
Clinicaltrials.gov ID: NCT00417612
